This disclosure relates to an aerosol delivery device for nebulizing a liquid for administration or delivery to a predetermined location in the interior or exterior of a human or animal. More particularly, this disclosure relates to an aerosol delivery device for use in ventilator applications to administer or deliver a liquid medicament or other liquid substance in aerosol form to a human's or animal's respiratory system, or for use in endoscopic applications to administer or deliver a liquid medicament or other liquid or substance in aerosol form.
Conventional jet nebulizers require a significant amount of air for their operation, typically 15 liters per minute (L/min). With a typical I:E ratio of 1:3 and 15 breaths per minute (BPM), such a nebulizer would generate 1,000 milliliters (mL) of aerosol during a typical 4-second period of inspiration expiration. The tidal volume of a healthy adult may be on the order of 700 mL and that of a pediatric patient will generally be far less. Consequently, the large air flows provided by conventional jet nebulizers, when introduced into a ventilator circuit, may cause the sensing mechanisms of the ventilator circuit to produce alarms and potentially shut down its operation.
Nebulizer systems, such as micro pump systems, do not require a supply of air flow for their operation. Thus, they may be used in neonatal and adult ventilator circuits without fear of conflicting with the ventilator circuit sensors. Although micro pump nebulizer systems address the potential air flow problems that may occur when used with ventilator circuits, the attachments for a micro pump nebulizer system that would be used with the ventilator circuit are generally heavy, especially for pediatric application. Furthermore, the micro pump nebulizer systems are generally required to be kept upright during use.
Another way in which nebulizing devices have been implemented to avoid conflicting with the sensing mechanisms of a ventilator is to utilize nebulizing systems for delivering target aerosol directly into the lungs such as a nebulizing catheter synchronized with a patient's breathing to aid in the delivery of expensive or potential toxic drugs, and also to reduce environment contamination with certain drugs. These types of nebulizing systems are typically driven by a control unit to make sure the pressures of producing the aerosol do not conflict with the ventilator circuit activity. Specifically, some nebulizing systems would use a separate control unit that synchronizes with the ventilation pressure and only produce aerosol during the initial stages of inhalation, for example the first 70 percent of inhalation. These nebulizing systems are generally designed for higher pressure gas supply operation, for example 100 pounds per square inch (p.s.i.) thereby requiring a separate compressor or gas cylinder in addition to the control unit that manages when the pressurized gas is applied to generated aerosol.
Accordingly, there is a need for an improved aerosol delivery system for use with ventilators that makes up for the above-noted issues.
In order to address the concerns of existing nebulizers and nebulizing systems that can be used with ventilator circuits, a ventilator aerosol delivery system is disclosed herein which may provide a lightweight portable system that can function without separate control units and use standard available sources of pressurized gas rather than higher pressure and/or adjustable pressure gas sources often used with nebulizing systems.
According to a first aspect an aerosol delivery system includes a vessel with a first end comprising a resealable fitting for connecting with a gas supply. The vessel also includes a body having a liquid reservoir and a gas passage independent of the liquid reservoir, where the liquid reservoir and the gas passage are in communication with gas supply via the resealable fitting, and where the body is configured to be adjacent to the resealable fitting when the resealable fitting is attached to the gas supply. A second end of the vessel is connected with a length of multi-lumen tubing. The second end defines a liquid path from the liquid reservoir to a liquid lumen in the multi-lumen tubing and a gas path from the gas passage to at least one gas lumen in the multi-lumen tubing. The aerosol delivery system also includes a tube adapter, such as an endotracheal tube adapter, having an inlet port connected to an end of the multi-lumen tubing, and tube opening sized to connect with a tube such as an endotracheal tube, where outlets for the gas and liquid lumens at the end of the multi-lumen tubing are arranged such that gas issuing from the at least one gas lumen and liquid issuing from the liquid lumen continuously form an aerosol inside the tube adapter. Gas received at the resealable fitting provides gas for both the at least one gas lumen and provides a pressure to any liquid in the liquid reservoir. In an alternative embodiment, the aerosol delivery system may be configured for use in endoscopic procedures rather than respiratory applications. For example, rather than being connected to an endotracheal tube adapter, the multi-lumen tubing may be connected to a tubing, such as a wye-tube, or to a device connected to the tubing, such as a gas warmer or gas warmer/humidifier device. The tubing carries a gas and in one embodiment the gas is CO2 and it is used in an endoscopic procedure, such as a laparoscopic procedure, for insufflating a body cavity and the multi-lumen tubing is used to administer, for example, a liquid such as H2O in aerosol form, to humidify or to further humidify the CO2 gas used to insufflate the body cavity.
The body of the vessel may have a one-way filling port positioned over the liquid reservoir of the vessel to permit refilling of the reservoir. The one-way filling port may be positioned at an angle from a vertical orientation of the body. The resealable fitting on the vessel may be configured to rigidly attach the vessel to an outlet of the gas supply, when the resealable fitting is tightened onto the outlet, so that orientation of the reservoir is maintained and the reservoir is kept away from the patient to avoid potential clutter at the location of treatment. The continuously formed aerosol produced in the endotracheal tube adapter at the end of the multi-lumen tubing may produce particle sizes in a range of 10-14 μm MMAD when gas at a pressure of 50 pounds per square inch (psi) is received at the resealable fitting.
For the purpose of facilitating an understanding of the subject matter sought to be protected, there is illustrated in the accompanying drawings an embodiment thereof, from an inspection of which, when considered in connection with the following description, the subject matter sought to be protected, its construction and operation, and many of its advantages should be readily understood and appreciated.
Referring to
As shown in
As best shown in
Referring again to
At the bottom end of the liquid vessel 14, as noted above, multi-lumen tubing 16 is attached at the bottom of the liquid reservoir 34. Additionally, adjacent to the multi-lumen tubing is an opening of the air passage 36. The bottom of the liquid vessel 14, surrounding the air passage opening 42 and the connection with the multi-lumen tubing 16, defines a connection hub 44. The connection hub 44 may attach to the liquid vessel 14 at a friction fit joint 46 and may additionally or alternatively be bonded or adhered. The multi-lumen tubing 16 may form an adhesive bonded fit, or be joined with the liquid vessel using any of a number of bonding or welding techniques, with the opening at the bottom of the liquid reservoir 34. The reservoir 34 is sealed to the proximal end of the multi-lumen tube in this manner not only to provide an air-tight connection and prevent leakage, but also to prevent switching the liquid vessel 14, or multi-lumen tubing 16 to another system 10, which could lead to contamination or performance issues. The reservoir 34 is replenished via a syringe connected via the luer-lock fitting of the one-way fill port 26
A liquid filter 48 is positioned at the junction of the reservoir 34 and the multi-lumen tubing 16 so as to remove any contaminants from liquid prior to entry into the multi-lumen tubing. The liquid filter 48 may be a stainless steel mesh or any of a number of other suitable liquid filters. In one embodiment, the stainless steel mesh of the liquid filter may be a steel mesh of approximately 15-25 micrometers (μm) pore size on the stainless steel carrier. The liquid filter 48 may be press fit into the bottom of the channel in the liquid reservoir.
At the initial portion of the multi-lumen tubing 16 where liquid from the liquid reservoir 34 enters the multi-lumen tubing 16, all of the lumens 50-52 receive liquid. Referring to
Further down the multi-lumen tubing 16, away from the liquid vessel with respect to the break 54, are lumen openings 56 that provide an avenue to communicate air coming from the air outlet 42 of the air passage 36 to the lumens 52 that were blocked at the break 54. Air traveling through the connection hub 44 is directed into the openings 56 and thus to the distal end of the multi-lumen tubing 16. In other words, pressurized air from the wall outlet 12 which passes through the air passage 36 in air outlet 42 into the connection hub 44 is then projected into the open lumens at the opening 56. Medicament from the liquid reservoir 34 in the liquid vessel 14 continues in the multi-lumen tubing 16 in a central lumen 50 and/or any other lumens not blocked at the blocking portion 54.
The distal end of the connection hub 44 is sealed around the multi-lumen tubing 16, for example with an adhesive or glue, to prevent gas leakage. A strain relief member 58 is attached to the end of the connection hub 44. The strain relief member 58 may be a bendable tip having a length sufficient to provide a transition between the rigid connection hub 44 and the more flexible multi-lumen tubing 16. Also, as best shown in
In operation, the multi-lumen tubing 16 leaving the strain relief region 58 contains the flow of air from the wall-mounted outlet 12 in the peripheral lumens 52 and liquid in the central lumen 50. The multi-lumen tubing 16 preferably extends from the liquid vessel 14 to an adapter such as the endotracheal tube adapter 18 over a distance of approximately 2 to 3 meters. The multi-lumen tubing 16 connects with the endotracheal tube (ETT) adapter 18 over a short strain relief sleeve 60 to provide strain relief at the point where the multi-lumen tubing and the endotracheal tube adapter meet. As shown in
The tip of the multi-lumen tubing 16 is preferably tapered such that the tubing 16 extends into the insertion port 64 slightly more than the sleeve 60 and the air and liquid lumens 52, 50 are oriented to mix the air and liquid into a nebulized mist 68 into the ETT adapter 18 as shown in
The size of the multi-lumen tubing 16 and lumens 50, 52 may be selected to achieve desired particle size and flow rates for a given gas pressure. In one embodiment the multi-lumen tubing 16 may have one central lumen and several outside lumens, typically 4 to 6, with nominal diameters of 0.012 inches and 0.02 inches respectively at the proximal end. The multi-lumen tubing can be provided in various lengths, with one suitable length being about 3 meters as mentioned above. At the tip of the multi-lumen tubing inside the insertion port 64, the outer lumens 52 may be sized with a diameter 0.0032±0.00015″ and the inner lumen (carrying the liquid under pressure provided from a portion of the gas supply of the wall outlet 12) may be size at a diameter of 0.0024±0.00005″. The outer lumens may be arranged on a 0.0074±0.00006″ pitch circle diameter. One can produce a different particle size distribution with the system by adjusting the lumen 50, 52 diameters while maintaining the same wall thickness between the lumens.
Preferably the multi-lumen tubing 16, liquid vessel 14, and filter element 48 will all be made of chemically-resistant materials suitable for working with the medications intended, including, without limitation, salbutemol, budesonide and ipratropium bromide. Generally these materials should satisfy USP class VI (ISO 10993-1). One generally good material for the multi-lumen tubing is a polyamide, such as Nylon-12. As noted above, the filter element 48 may be a stainless steel mesh of a stainless steel carrier. I an alternative embodiment, the filter may be a monofilament polyamide, such as Nylon 6-6 (Sefar Medifab). Other materials are contemplated. The endotracheal tube adapter 18 and the components of the liquid vessel 14 generally should be made of a durable, biocompatible material with a reasonable degree of impact resistance. As noted above, the main body 24 of the liquid vessel 14 may be clear or have a clear section to provide a room for visual assessment of the amount of liquid within reservoir 34. One suitable material for these components is Zylar (a styrene methyl methacrylate acrylic copolymer).
The connector 20 at the side of the of the inlet module 22 of the liquid vessel 14 may be made from ABS or other material with a suitable strength. The one-way fill port 26 may be made from a combination of materials, such as ABS and silicone rubber. The strain reliefs tip 58 and sleeve 60 may be made from a flexible material that can be readily bonded to the associated parts. The strain relief tip and sleeve 58, 60 are preferably not in contact with the medical gas or liquid medication and a suitable material for these elements is PVC or polyurethane. Also, the bonding of adjacent parts in the system 10 should satisfy biocompatibility requirements for any of the airways or liquid pathways. Examples of suitable bonding techniques include ultrasonic welding or UV-curing adhesives. Although reusable versions are contemplated, the aerosol delivery system 10 is preferably a single-use, disposable item.
Although numerous configurations are contemplated, in one implementation, the following dimensions may be used. The liquid vessel 14 may have an inlet module 22 that fits within a 24×13 mm cross-section and is approximately 34 mm high for a 10 mL reservoir 34, or can fit in a 48×42 mm cross-section and is approximately 42 mm high for a 100 mL reservoir 34. The main body of a 10 mL version and a 100 ml version may be 83 mm high and 126 mm high, respectively, and fit within the same respective cross-sections identified above. The one-way filling port 26 may be 1.75″ long with a 0.25″ outside diameter and a 0.375″ diameter outer flange. The connection hub 44 may fit within a 0.3″×0.5″ cross-sectional area and is nominally 1.4″ to 1.8″ in length. The strain relief tip 58 is nominally 25 mm in length with inside dimensions to fit the tip of the Connection Hub 44 and the nominal 2-mm-diameter proximal end of the multi-lumen tubing 16. In the liquid vessel 14, the air passage 36 within the main body 24 is nominally 4×8 mm in cross-section. For the portion of the air inlet 28 that branches into the liquid reservoir air channel 32, the nominal ⅛″ diameter inlet 28 is divided into two channels that provide inlets to the air passage 36 and the inlet to the liquid reservoir 34. The inlet of the liquid reservoir air channel 32 to the liquid reservoir 34 is on the order of 1.5 mm2. Also, the inside and outside diameters of the strain relief sleeve 60 are nominally 1/16″ and ⅛″ respectively, with a length sufficient to provide a snug fit at its proximal contact with the multi-lumen tubing 16. This length may be typically 30 cm.
In operation, the system 10 provides for continuous aerosolization of a medication that has been provided in a suitable concentration to permit continuous delivery until the reservoir 34 of the liquid vessel 14 is empty. A brief description of system set-up and operation is described below. A packaged system 10 may be opened by a healthcare provider and inspected for any signs of damage or broken seals on the package. After removal from the packaging, the healthcare provider connects the connector 20, such as a 9/16-18 UNF female connector, to the supply of medical gas from a wall-mounted flow-meter 12. The multi-lumen tubing 16 is then uncoiled and the endotracheal tube adapter 18 may be connected the endotracheal tube, a suction catheter (if required) and ventilator circuit. Clips or other suitable restraints may be applied along the length of the multi-lumen tubing 16, as necessary, to ensure that the tubing 16 does not accidentally experience excessive forces while in use.
Once the system 10 is secured and assembled, the healthcare provider may provide medicament to the reservoir 34 or the system 10 may be prefilled and packaged with the desired medication. In one implementation, it is contemplated that the healthcare provider could insert a pre-filled syringe into the one-way filling port 26 and twist the tapered Luer connection of the port to ensure a firm contact. If necessary, the healthcare provider may repeat this filling process until the desired volume of liquid medication is in the reservoir 34. The graduations 40 on the main body 24 of the liquid vessel 14 may be used to confirm that the desired amount of medication has been introduced into the liquid vessel 14. The flow through the flow regulator of the healthcare facility wall outlet 12 may now be adjusted to maximum, since the dimensions of the outer lumens of the multi-lumen tubing will govern the flow-rate of air exiting the tip of the multi-lumen tubing 16 in the ETT adapter 18. At this stage, the aerosol 66 generated at the tip of the multi-lumen tubing 16 will begin to be delivered into an ET Tube (not shown) connected to the ETT adapter 18. If the liquid vessel 14 requires re-filling during the treatment of the patient, the fresh liquid medication can be introduced using a syringe while the circuit is still pressurized at 50 psi. The pressure required on the plunger of the syringe when filling a pressurized circuit will be greater than when the circuit was not pressurized, but should still be achievable with a force applied by the thumb and fingers of one hand. When the treatment is complete, the flow meter to may be adjusted to zero flow, the 9/16-18 UNF female connector removed from the flow meter, and the system 10 disconnected from the ET Tube, suction catheter (if present), and the ventilator circuit. The system 10 should then be completely disposed of as required by the procedures of the healthcare facility.
An additional embodiment directed to an apparatus for use in an endoscopic procedure is illustrated in
As shown in
The housing 126 of the gas humidifier includes a first port 116 that allows fluid to be infused by syringe, gravity feed through tubing, or by any number of pumps, to the humidification material 124. The fluids infused may include sterile water, medication, or a mixture of fluids required for merely humidification or dispensing of medication. The interior end of the port 116 is positioned so that infused fluids drip into the housing 116 and are soaked up by the entire humidification material 124 by capillary action. The housing 126 may also include a second port 118. The second port 118 is positioned between the humidification material 124 and the outlet 128 so as to allow a distal end of a catheter, such as the multi-lumen tubing 16, to be inserted into the port 118. Depending on the intended material to be delivered to the patient, the distal end of the catheter may be positioned within the port 118, within the interior of the gas humidification apparatus 100 or within a tube attached to the outlet 128 and in fluid communication with a section of a patient, or within the section of the patient. An example of a catheter that can be inserted into the gas humidification apparatus 100 is the catheter described in U.S. Pat. No. 5,964,223, previously incorporated by reference. Other devices can be inserted into the port 118 in a similar manner, such as a lumen and an endoscope. Furthermore, gases, liquids, aerosols and medicines may be conveyed to a patient by a tube or other know dispensing devices inserted through the port 118 and exiting out of the outlet 128 into the patient. Note that the materials dispensed into the port 118 by the above-mentioned dispensing devices may have properties that raise the humidity of the gas within the interior of the gas humidification apparatus 100.
The gas humidification apparatus 100 may include control circuitry 120 that is in communication with the housing via inlet port 115. The control circuitry may include temperature sensors, humidity sensors and control circuitry so that the temperature and humidity of the gas flowing within the apparatus and delivered to a patient is controlled. In the implementation of
An aerosol delivery system 10 has been described that, in one implementation, may be a single-use (disposable) continuous nebulizer system designed for use with mechanically ventilated patients to aerosolize physician-prescribed medications for inhalation which are approved for use with a general purpose nebulizer. The system 10 separates the liquid reservoir from the nebulization process taking place at the adapter hub where it fits into an endotracheal tube (ETT) by a long (for example 3 meter) multi-lumen tube 16 comprising multiple outer lumens 52 supplying air with the central lumen 50 containing the liquid to be nebulized as the result of the Venturi effect at its distal end where it comes into contact with the air supply. The liquid reservoir 34 can therefore be mounted away from the immediate treatment zone, avoiding concerns about the effect of orientation that are associated with other types of nebulizers having a self-contained reservoir. The system can produce aerosols having a wide range of droplet sizes, depending upon central lumen diameter, with values of MMAD that range from 4 to 30 μm. In another implementation, the aerosol delivery device may be configured for non-respiratory applications, such as endoscopic procedures including laparoscopy, for example by inserting the distal end of the multi-lumen tubing into an inlet port of a tubing, a gas warmer, a gas warmer/humidifier or other device suitable for use in an endoscopic procedure, rather than into an endotracheal tube adapter.
It is therefore intended that the foregoing detailed description be regarded as illustrative rather than limiting, and that it be understood that it is the following claims, including all equivalents, that are intended to define the scope of this invention.
This application is a continuation of U.S. application Ser. No. 14/664,443, filed Mar. 20, 2015, pending, which U.S. application Ser. No. 13/216,759, filed Aug. 24, 2011, now U.S. Pat. No. 9,032,951, which claims the benefit of U.S. Provisional Application No. 61/376,644, filed Aug. 24, 2010, wherein the entirety of each of the aforementioned applications is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3019646 | Gavin | Feb 1962 | A |
3864326 | Babington | Feb 1975 | A |
3871373 | Jackson | Mar 1975 | A |
3912795 | Jackson | Oct 1975 | A |
4381267 | Jackson | Apr 1983 | A |
4537188 | Phuc | Aug 1985 | A |
4986269 | Hakkinen | Jan 1991 | A |
5031613 | Smith et al. | Jul 1991 | A |
5186166 | Riggs et al. | Feb 1993 | A |
5277175 | Riggs et al. | Jan 1994 | A |
5313939 | Gonzalez | May 1994 | A |
5355872 | Riggs et al. | Oct 1994 | A |
5438982 | MacIntyre | Aug 1995 | A |
5474059 | Cooper | Dec 1995 | A |
5483953 | Cooper | Jan 1996 | A |
5522385 | Lloyd et al. | Jun 1996 | A |
5579758 | Century | Dec 1996 | A |
5584285 | Salter et al. | Dec 1996 | A |
5642730 | Baran | Jul 1997 | A |
5884846 | Tan | Mar 1999 | A |
5906198 | Flickinger | May 1999 | A |
5964223 | Baran | Oct 1999 | A |
6079413 | Baran | Jun 2000 | A |
6116516 | Gañán-Calvo | Sep 2000 | A |
6119953 | Gañán-Calvo et al. | Sep 2000 | A |
6234402 | Gañán-Calvo | May 2001 | B1 |
6340023 | Elkins | Jan 2002 | B2 |
6357670 | Gañán-Calvo | Mar 2002 | B2 |
6405936 | Gañán-Calvo | Jun 2002 | B1 |
6526976 | Baran | Mar 2003 | B1 |
6536423 | Conway | Mar 2003 | B2 |
6595202 | Gañán-Calvo | Jul 2003 | B2 |
6729334 | Baran | May 2004 | B1 |
6766801 | Wright | Jul 2004 | B1 |
6792940 | Gañán-Calvo | Sep 2004 | B2 |
7059319 | Ganan-Calvo | Jun 2006 | B2 |
7059321 | Ganan-Calvo | Jun 2006 | B2 |
7267121 | Ivri | Sep 2007 | B2 |
7290541 | Ivri et al. | Nov 2007 | B2 |
7334580 | Smaldone et al. | Feb 2008 | B2 |
7448376 | Lepel | Nov 2008 | B2 |
7469700 | Baran | Dec 2008 | B2 |
7472705 | Baran | Jan 2009 | B2 |
7600511 | Power et al. | Oct 2009 | B2 |
7607436 | Smaldone et al. | Oct 2009 | B2 |
7712466 | Addington et al. | May 2010 | B2 |
7748377 | Smith et al. | Jul 2010 | B2 |
8051854 | Faram | Nov 2011 | B2 |
8193944 | Caso | Jun 2012 | B2 |
8246607 | Karpowica | Aug 2012 | B2 |
8322334 | Lee et al. | Dec 2012 | B2 |
9032951 | Finlay | May 2015 | B2 |
9132213 | Krupa | Sep 2015 | B2 |
9901690 | Finlay | Feb 2018 | B2 |
20020072700 | Mantell et al. | Jun 2002 | A1 |
20040084049 | Baran | May 2004 | A1 |
20040084050 | Baran | May 2004 | A1 |
20040154617 | Enk | Aug 2004 | A1 |
20060054166 | Knoch | Mar 2006 | A1 |
20070049841 | Lepel | Mar 2007 | A1 |
20070137648 | Addington et al. | Jun 2007 | A1 |
20070219532 | Karpowicz | Sep 2007 | A1 |
20080066741 | LeMahieu et al. | Mar 2008 | A1 |
20080230053 | Kraft et al. | Sep 2008 | A1 |
20080283051 | Faram | Nov 2008 | A1 |
20090050141 | King et al. | Feb 2009 | A1 |
20090308384 | Power et al. | Dec 2009 | A1 |
20100204602 | Addington et al. | Aug 2010 | A1 |
20110105936 | Addington et al. | May 2011 | A1 |
20120167878 | Belson et al. | Jul 2012 | A1 |
Number | Date | Country |
---|---|---|
0 692 273 | Jan 1996 | EP |
0 630 272 | Apr 2000 | EP |
0 687 478 | Sep 2001 | EP |
0 692 273 | Apr 2004 | EP |
9317744 | Sep 1993 | WO |
WO 2004011070 | Feb 2004 | WO |
2004071368 | Aug 2004 | WO |
2004071368 | Aug 2004 | WO |
2008094219 | Aug 2008 | WO |
2009117422 | Sep 2009 | WO |
2009117422 | Sep 2009 | WO |
2010008424 | Jan 2010 | WO |
Entry |
---|
European Directorate for the Quality of Medicines (EDQM), Preparations for Nebulisation: Characterisation (2.9.44), Pharm. Europa, 2006,18(2):280-282. |
Fink, James B., New Technology Offers New Opportunities: Continuous Bronchodilator Therapy During Mechanical Ventilation, Respiratory Therapy, Aug.-Sep. 2007, 2(4):29-32. |
Finlay, J. B. et al., Delivery of Medication as Large Particles at the Carina of an In Vitro Lung Model is Effective Using a Nebulizing Catheter, Drug Delivery to the Lungs—16, Edinburgh, UK, Dec. 2005, pp. 34-37. |
Günther, A. et al., Tidal Volume in Mechanical Ventilation: The Importance of Considering Predicted Body Weight, Am. J. Respir. Crit. Care Med., 2008,178:315-316. |
Hess, Dean R., Nebulizers: Principles and Performance, Respir. Care, Jun. 2000, 45(6):609-622. |
Instruction manual for the Aeroneb® Solo System Micropump Nebulizer, Aerogen Ltd, Galway, Ireland, 2009 available at: http://aerogen.com/uploads/File/TrainingMaterial/Solo/Aeroneb%20Solo%20DFU%20%20Rev%20F%20-%20EN.pdf. |
International Preliminary Report on Patentability issued in international application No. PCT/IB2011/001936, dated Feb. 26, 2013 (6 pages). |
Kesser, K. C., et al., New Aerosol Delivery Devices for Cystic Fibrosis, Respiratory Care, Jun. 2009, 54(6):754-768. |
McPeck Michael, et al., Aerosol Delivery During Continuous Nebulization, Chest. 1997, (111):1200-1205. |
Mitchell, J. P., et al., Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 1, AAPS PharmSciTech, 2010, 11(2):843-851. |
Mitchell, J. P., et al., Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2—Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor, AAPS PharmSciTech, 2010, 4 pages. |
Usmani, O. S., et al., Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols, J Appl Physiol, 2003, 95:2106-2112. |
Usmani, O. S., et al., Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size, Am. J. Respir. Crit. Care Med., vol. 172, 2005, 172:1497-1504. |
European Search Report issued in European application No. EP11871358.5, dated Mar. 13, 2015. |
Number | Date | Country | |
---|---|---|---|
20180272082 A1 | Sep 2018 | US |
Number | Date | Country | |
---|---|---|---|
61376644 | Aug 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14664443 | Mar 2015 | US |
Child | 15874647 | US | |
Parent | 13216759 | Aug 2011 | US |
Child | 14664443 | US |